Current treatment options for paroxysmal supraventricular tachycardia
Open Access
- 28 February 1994
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 127 (2) , 475-480
- https://doi.org/10.1016/0002-8703(94)90151-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.Circulation, 1991
- Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern.Circulation, 1990
- Adenosine for Paroxysmal Supraventricular Tachycardia: Dose Ranging and Comparison with VerapamilAnnals of Internal Medicine, 1990
- Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter studyJournal of the American College of Cardiology, 1989
- Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1988
- Long-term efficacy and safety of flecainide for supraventricular tachycardiaThe American Journal of Cardiology, 1988
- RELATIVE EFFICACY OF VARIOUS PHYSICAL MANOEUVRES IN THE TERMINATION OF JUNCTIONAL TACHYCARDIAThe Lancet, 1988
- Sotalol Infusion in the Treatment of Supraventricular TachyarrhythmiasChest, 1985
- Oral Verapamil for Paroxysmal Supraventricular TachycardiaAnnals of Internal Medicine, 1982
- Effects of amiodarone studied by programmedelectrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardiaJournal of Electrocardiology, 1978